IL10 and multiple sclerosis: In a multiple sclerosis model, Alberti et al. (2017) reported that BCP reduced IFN-γ and increased IL-10 production in T cells treated with MOG35-55 peptide in vitro, and prevented microglial activation and demyelination in C57BL/6 mice in vivo [54].